Prothena to be Added to NASDAQ Biotechnology Index and NASDAQ Global … – NASDAQ
|
Prothena to be Added to NASDAQ Biotechnology Index and NASDAQ Global …
NASDAQ DUBLIN, Ireland, Dec. 30, 2013 (GLOBE NEWSWIRE) — Prothena Corporation plc (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery, development and commercialization of novel antibodies for the potential treatment of a … |
